Biocon Ltd. — Board/Management Information 2020

May 14, 2020

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

May 14, 2020

To, The Manager BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001	To, The Manager National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - Biocon

Subject: Appointment of Interim Chief Financial Officer (‘Interim CFO’) and Key Managerial Personnel of the Company.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

Dear Sir/Madam,

With reference to the captioned subject, we would like to inform you that the Board of Directors at its meeting held today, has approved the appointment of Mr. Indranil Sen, Vice - President, Finance as an Interim CFO and Key Managerial Personnel of the Company, pursuant to the provisions of Section 203 of the Companies Act, 2013, effective from May 15, 2020.

The Board is in process of selecting full time Chief Financial Officer of the Company.

In compliance with Regulation 30 of SEBI Listing Regulations, please find enclosed herewith the required disclosures as Annexure A.

The above information will also be available on the website of the company at www.biocon.com.

Kindly take the above information on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [97 x 37] intentionally omitted <==

==> picture [77 x 81] intentionally omitted <==

---

Mayank Verma Company Secretary and Compliance Officer

ANNEXURE A

Details under Regulation 30 of the SEBI Listing Regulations read along with SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015

S. No.	Particulars	Remark
1.	Name	Mr. Indranil Sen
2.	Reason for change viz. appointment, resignation, removal, death or otherwise;	Appointment
3.	Date of appointment/ cessation (as applicable) & term of appointment;	Effective from May 15, 2020
4.	Brief profile (in case of appointment);	Attached asAnnexure B
5	Disclosure of relationships between directors (in case of appointment of a director).	None

ANNEXURE B

Brief Profile of Mr. Indranil Sen

==> picture [129 x 146] intentionally omitted <==

Mr. Indranil Sen, Vice President, Finance, is the current Finance Controller and Head of Business Finance for Small Molecules in Biocon Limited.

He is a qualified Chartered Accountant from the Institute of Chartered Accountants of India, New Delhi. He has over 17 years of extensive experience in the finance domain in the realms of financial planning, treasury, taxation and financial reporting.

He has been a part of Biocon for 6 years, performing various key leadership roles in the finance function.

He started his career in statutory audit and has worked in the audit division of B.S.R & Co (Indian arm of KPMG) in Kolkata and S.R. Batliboi & Co. (Indian arm of Ernst & Young) based out of Bengaluru. Prior to joining Biocon, he was the Director, Finance with Symphony Teleca, a leading US-based multinational IT Company.